Universal Screening for SARS-CoV-2 in Asymptomatic Pregnant
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Novel coronavirus (SARS-CoV-2) is responsible for the current global pandemic and understandably, Obstetrics is not spared. This has led to routine SARS-CoV-2 testing of all patients before admission in many of the private hospitals in India.

The current study was undertaken to determine the incidence of SARS-COV-2 among asymptomatic pregnant women and to ascertain the utility of universal screening in these women.

A retrospective observational multi-center study was conducted over a period of approximately 5 months in a chain of privately run maternity hospitals with a presence in multiple cities across India. All asymptomatic pregnant women were tested for SARS-CoV-2 prior to elective/emergency hospital admission.

Among 4158 women tested, 54 (1.3%) were positive for SARS-CoV-2, and the intrapartum and postnatal period was uneventful for all of them.

Conclusively, universal screening should be continued as a preferred approach to ensure low anxiety levels of delivering women and safety of frontline workers. Further, universal screening helps avoid the emergence of maternity centers as virus clusters by effective isolation of identified positive cases and minimizing points of contact.

The Journal of Obstetrics and Gynecology of India
Source: https://doi.org/10.1007/s13224-021-01476-z
Like
Comment
Share